External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ARVO 2025
Roche and Genentech at

ARVO 2025

May 04 - May 08
Salt Lake City, USA
arvo.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:00 PM
Duration 105mins Salt Lake City, USA
Pigment Epithelial Detachment Thickness Fluctuations in the Archway Trial of the Port Delivery Platform With Ranibizumab (PDS)
Brodie F, Graff J, Lai T, Malik D, Ruiz-Medrano J, Priglinger S, Blotner S, Gordon A, Holekamp N, Prager A, Heinrich D
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Impact of PDS Treatment in Study Eyes vs Anti-VEGF Injections in Fellow Eyes on Efficacy and Safety Outcomes in Patients With Bilateral DME in the Pagoda Trial
Wirthlin R, Eichenbaum D, Graff J, Udaondo P, Hsieh YT, Hsu J, Blotner S, Gune S, Jones M, Santhanakrishnan A, Schimpl A, Heinrich D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Retinal Fluid and Thickness Fluctuations in Patients With Diabetic Macular Edema: Results From the Pagoda Trial of the Port Delivery Platform With Ranibizumab (PDS)
Marcus D, Tan G, Awh C, Eter N, Hatz K, Menezes A, Eghoej M, Gordon A, Blotner S, Heinrich D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Sustained Suppression of Aqueous Humor Free VEGF Following Continuous Delivery via the PDS in the Pagoda and Pavilion Trials
Maass K, Gill M, Javey G, Chang M, Hsu J, Hyung S, Latkany P, Tian K
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Volumetric Analysis of Retinal Fluids in Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) in Patients With nAMD
Sheth V, Chakravarthy U, Blotner S, Heinrich D, Neubert A, Orduna J, Yu S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:00 PM
Duration 105mins Salt Lake City, USA
Intravitreal IL-6 Inhibition With Vamikibart in Uveitic Macular Edema (UME): Baseline Characteristics of the DOVETAIL Phase 1 Study
Meike Pauly-Evers, Hu A, Lin P, Suhler E, Zeinab Barekati, William Holmes, Laura Steeples, Zdenka Haskova, Sascha Fauser, Marina Mesquida
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Real-World Treatment Patterns In Patients With Macular Edema (ME) Due To Noninfectious Uveitis (NIU) In The United States
Eichenbaum D, Steeples L, Mesquida M, Stoilov I, Dayal P, Kavanagh L, Haskova Z
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Faricimab▼ Real-World Data Support Clinical Trial Data in Patients With Treatment-Naïve nAMD: Results From TENAYA/ LUCERNE and FARETINA/FARWIDE
Jay Berdia, Haug S, Avery R, Souied E, Bonine N, Chi G, Dayal P, Amador M, Kotecha A, Margaron P, Yang M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses
Colin Tan, Gallego-Pinazo R, Koh A, Pitcher J, Dagincourt N, Hill L, Yang M, Patel S, Margaron P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:00 PM
Duration 105mins Salt Lake City, USA
Quantitative Ultra-Widefield Fluorescein Angiography for the Assessment of Novel Biomarkers of Vascular Stability With Faricimab▼: A YOSEMITE/RHINE Post Hoc Analysis
Justis Ehlers, Matar K, Indurkar A, Della Vecchia L, Amine R, Mamone J, Tang A, Gibson K, Dagincourt N, Mar F, Amador M, Warter A, Sim D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Update on Faricimab▼ for DME: New Clinical Features of Eyes in the RHONE-X study
Michael Singer, Arshad Khanani, Francis Abreu, Kara Gibson, Alex Kotak, Timothy Y. Y. Lai, Ian Pearce, Patricio Schlottmann, Dawn A. Sim, Yannan Tang, Aachal Kotecha
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Treatment Response and Safety of Faricimab▼ in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the US
Joseph Coney, Amador M, Brown J, Cunningham M, Emanuelli A, Huddleston S, Milunovich S, Scott A, Yang M, Lu X-Y, Gonzalez L
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Effectiveness and Safety of Faricimab▼ in Eyes With DME in the United Kingdom: 1-Year Results From the FARWIDE-DME Study
Tunde Peto, Sivaprasad S, Reynolds R, Bailey C, Downey L, Kiire C, Pearce I, Dayal P, James N, Rothwell A, Shah N, Downey A, Dodds M, Chi G
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Two-Year Real- World Clinical Outcomes in Patients With Diabetic Macular Edema Treated With Faricimab▼ in the US: The FARETINA-DME Study
Singh R, Zwick E, Bonine N, Leng T, Stella K, Shaia J, Ali F, Borkar D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Prevalence of Retina Conditions: A Focus on Underserved Populations by Regions in the US in 2022
Ko S, Bonine N, Borkar D
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration - Retinal Vein Occlusion - Diabetic Retinopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:15 PM
Duration 15mins The Calvin L. Rampton Salt Palace Convention Center
Indirect Comparison of the Relative Effectiveness of Faricimab▼ vs Aflibercept 8 mg in DME and nAMD
Eric Nudleman, Keane P, Holekamp N, Leng T, Siedlecki J, Mar F, Gibson K, Margaron P, Paulo T, Buehrer C, Tabano D
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:30 PM
Duration 15mins The Calvin L. Rampton Salt Palace Convention Center
Faricimab▼ for Polypoidal Choroidal Vasculopathy: Week 16 Results From the Phase 3b/4 SALWEEN Trial
Junyeop Lee, Cheung G, Chen S-J, Iida T, Koh A, Lee W K, Ruamviboonsuk P, Sun X, Yanagi Y, Bai R, Margaron P, Nguyen Duc A, Lai T YY
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:30 PM
Duration 105mins Salt Lake City, USA
Global Real-World Clinical and Anatomical Outcomes With Faricimab▼ in Treatment-Naïve Patients With nAMD or DME From a Prospective Noninterventional Study: The VOYAGER Study
Robyn Guymer, Steffen Schmitz-Valckenberg, Clare Bailey, Voraporn Chaikitmongkol, Varun Chaudhary, Gloria Chi, Amanda Downey, Robert Finger, Adrian Koh, Susumu Ishida, Monica Lövestam-Adrian, Mariacristina Parravano, Jose Luna Pinto, Veeral Sheth, Beijue Shi, Eric Souied, Diane Uschner
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Effectiveness and Safety of Faricimab▼ in Eyes With nAMD in the United Kingdom: 18-Month Results From the FARWIDE-nAMD Study
Deepali Varma, McKibbin M, Talks J, DeSalvo G, Patel P, DeSilva S, Gale R, Dayal P, James N, Rothwell A, Shah N, Downey A, Dodds M, Chi G
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Two-Year Real-World Clinical Outcomes in Patients With Neovascular Age-Related Macular Degeneration Treated With Faricimab▼ in the US: The FARETINA-nAMD Study
Borkar D, Zwick E, Bonine N, Leng T, Stella K, Shaia J, Ali F, and Singh R
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:30 PM
Duration 105mins Salt Lake City, USA
Volumetric Analysis of Hard Exudates on Optical Coherence Tomography: Biomarker Results of Faricimab▼ vs Aflibercept From the Phase 3 YOSEMITE/RHINE Trials
Stela Vujosevic, Andreas Pollreisz, Christiana Dinah, Roger Goldberg, Michael Ip, Ehsan Rahimy, Manuel Amador, Isabel Bachmeier, Kara Gibson, Andreas Maunz, Olivia O’Leary, Diane Uschner
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Ultra-Responders to Faricimab▼: ≥ 4-Step Improvement in Diabetic Retinopathy Severity in YOSEMITE/RHINE
Samir Patel, Michael Klufas, Jason Hsu, Warter A, Nicholas Dagincourt, Gibson K
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Salt Lake City, USA
Predictors of Extended Treatment Intervals in Patients With DME Treated With Faricimab▼ in the Phase 3 YOSEMITE/RHINE Trials
Bianca Gerendas, Ambresin A, Arevalo F, Gibson K, Sim D, Hill L , Yang M
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:00 PM
Duration 105mins Salt Lake City, USA
Association of Early Macular Leakage Resolution With Extended Dosing Intervals in Patients With RVO: A BALATON/COMINO Post Hoc Analysis
Harit K Bhatt, Joern Schwitzer, Jan Thommen, Nicholas Dagincourt, Liliana Paris Pereira
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:00 PM
Duration 105mins Salt Lake City, USA
Gold Standard vs. Ultrawide Field Imaging for Diabetic Retinopathy Severity: Results from YOSEMITE/RHINE Phase 3 Studies
Domalpally A, Tang Y, Willis J, Gibson K, Khanani A, Wykoff C, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:00 PM
Duration 105mins Salt Lake City, USA
Characterization of a Tailored Bi-Specific DutaFab, Zifibancimig, for Neutralizing Both VEGF-A and Ang-2, and Continuous Ocular Delivery via the Port Delivery Platform
Moelleken J, Molhoj M, Benz J, Caruso A, Fenn S, Fueth M, Monnier CA, Speck J, Ullmer C
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.